Formosa Pharmaceuticals Investors
Financials
Consolidated Financial Statements
Parent Company Only Financial Statements
News Highlight
Cipla and Formosa sign their first multi-regional licensing deal for Clobetasol Suspension
2025-03-13
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11
